Rise Advisors’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-275
Closed -$12.3K 1549
2024
Q4
$12.3K Hold
275
0.01% 925
2024
Q3
$12.5K Hold
275
0.01% 947
2024
Q2
$9.14K Hold
275
﹤0.01% 1034
2024
Q1
$13.2K Hold
275
0.01% 947
2023
Q4
$20.3K Sell
275
-315
-53% -$21.3K 0.01% 250
2023
Q3
$43.1K Hold
590
0.03% 149
2023
Q2
$48.9K Sell
590
-200
-25% -$17.5K 0.04% 147
2023
Q1
$70.4K Sell
790
-100
-11% -$8.7K 0.05% 129
2022
Q4
$76.2K Sell
890
-380
-30% -$32.2K 0.06% 122
2022
Q3
$91K Hold
1,270
0.08% 101
2022
Q2
$123K Buy
+1,270
New +$129K 0.12% 84

Other funds holding QDEL

Rise Advisors's QDEL Position: Q1 2025 in Review

Rise Advisors sold out of QuidelOrtho (QDEL) in Q1 2025, closing a stake of 275 shares — an estimated $12.3K sold.

Rise Advisors first reported a position in QDEL in Q2 2022 and held it in 11 quarters. The position peaked at $123K in Q2 2022. 266 funds tracked by Wall St. Rank hold QDEL as of Q1 2025.

  • Rise Advisors reported no remaining QuidelOrtho position as of Q1 2025 after selling out during the quarter.
  • Rise Advisors sold 275 QuidelOrtho shares in Q1 2025, an estimated $12.3K.
  • Rise Advisors first reported a position in QuidelOrtho in Q2 2022 and held it in 11 quarters.
  • Rise Advisors's QuidelOrtho position peaked at $123K in Q2 2022.
  • 266 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2025.

Based on Rise Advisors's 13F filing for Q1 2025, filed 15 May 2025.